MCP
ARKG icon

Militia Capital Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Militia Capital Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48,600
Closed -$1.18M – 179
2025
Q2 		$1.18M Buy
+48,600
New +$1.06M 0.55% 50

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Militia Capital Partners's ARKG Position: Q3 2025 in Review

Militia Capital Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2025, closing a stake of 48,600 shares — an estimated $1.18M sold.

Militia Capital Partners first reported a position in ARKG in Q2 2025 and held it in 1 quarter. The position peaked at $1.18M in Q2 2025. 233 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.

  • Militia Capital Partners reported no remaining ARK Genomic Revolution ETF position as of Q3 2025 after selling out during the quarter.
  • Militia Capital Partners sold 48,600 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $1.18M.
  • Militia Capital Partners first reported a position in ARK Genomic Revolution ETF in Q2 2025 and held it in 1 quarter.
  • Militia Capital Partners's ARK Genomic Revolution ETF position peaked at $1.18M in Q2 2025.
  • 233 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.

Based on Militia Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.